1. Home
  2. SAIC vs GKOS Comparison

SAIC vs GKOS Comparison

Compare SAIC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAIC
  • GKOS
  • Stock Information
  • Founded
  • SAIC 1969
  • GKOS 1998
  • Country
  • SAIC United States
  • GKOS United States
  • Employees
  • SAIC N/A
  • GKOS N/A
  • Industry
  • SAIC EDP Services
  • GKOS Medical/Dental Instruments
  • Sector
  • SAIC Technology
  • GKOS Health Care
  • Exchange
  • SAIC Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • SAIC 4.8B
  • GKOS 5.4B
  • IPO Year
  • SAIC N/A
  • GKOS 2015
  • Fundamental
  • Price
  • SAIC $103.93
  • GKOS $80.58
  • Analyst Decision
  • SAIC Hold
  • GKOS Strong Buy
  • Analyst Count
  • SAIC 9
  • GKOS 12
  • Target Price
  • SAIC $121.89
  • GKOS $128.58
  • AVG Volume (30 Days)
  • SAIC 524.1K
  • GKOS 647.5K
  • Earning Date
  • SAIC 09-04-2025
  • GKOS 11-03-2025
  • Dividend Yield
  • SAIC 1.42%
  • GKOS N/A
  • EPS Growth
  • SAIC 49.05
  • GKOS N/A
  • EPS
  • SAIC 8.26
  • GKOS N/A
  • Revenue
  • SAIC $7,460,000,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • SAIC $4.04
  • GKOS $28.79
  • Revenue Next Year
  • SAIC $2.21
  • GKOS $25.65
  • P/E Ratio
  • SAIC $12.59
  • GKOS N/A
  • Revenue Growth
  • SAIC 2.23
  • GKOS 26.70
  • 52 Week Low
  • SAIC $94.68
  • GKOS $77.10
  • 52 Week High
  • SAIC $156.34
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • SAIC 32.17
  • GKOS 31.05
  • Support Level
  • SAIC $101.43
  • GKOS $86.81
  • Resistance Level
  • SAIC $107.43
  • GKOS $95.32
  • Average True Range (ATR)
  • SAIC 2.92
  • GKOS 2.84
  • MACD
  • SAIC -1.15
  • GKOS -1.21
  • Stochastic Oscillator
  • SAIC 13.03
  • GKOS 0.30

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: